The retrospective matched cohort study used data from a centralized registry of patients evaluated by neuro-ophthalmologists at an academic institution between December 2017 and November 2023
In February 2021, the researchers published the findings from their trial in The New England Journal of Medicine, showing that patients using semaglutide lost almost 15% of their body weight, on average, compared with 2.4% among patients who got the placebo
Getting the financing right can save hundreds of dollars annually
"Best" refers only to visibility, transparency, and public information, not clinical outcomes or quality
Why GLP One in Louisiana Has Become a Trusted Option Glp one in Louisiana is rapidly establishing itself as a reliable and evidence-based choice for residents seeking sustainable results
Nayan Patel: Oh, thank you